FDA Warnings
Leg Amputations by Invokana
Collectively, these newly identified effects of Invokana on heart and kidney disease show significantly enhanced benefits of this medicine. Safety information from recent clinical trials also suggests that the risk of amputation, while still increased with canagliflozin, is lower than previously described, particularly when appropriately monitored. Based on these considerations, we have concluded that the Boxed Warning should be removed. FDA ALSO SEE: FDA approvals SGLT2 inhibitor Invokana FDA Boxed Warning Invokana September 2020 Based…
Published
FDA Warning: Biotin (B7) Interferes with Heart Test
The FDA has now released a new warning against biotin interference with troponin, an essential heart blood test. Biotin or vitamin B7 is a water-soluble molecule found in many over-the-counter supplements such as multivitamins, prenatal, and in those that are meant to improve or protect the health of hair, skin, and nail. Vitamin B7 is a central catalyst in many laboratory tests, especially those measuring troponin and thyroid hormone levels. When patients take high doses…
Published
Categorized as Blog, FDA Warnings, Heart Health, Insights from Dr. Tashko, Technology, Thyroid Health